HY-126250-5mg
|
MedChemexpress LLC
|
NPD-1335 [CAS 2376326-31-5]
|
|
COVID-19-immunoregulation
|
|
HY-126250-50mg
|
MedChemexpress LLC
|
NPD-1335 [CAS 2376326-31-5]
|
|
COVID-19-immunoregulation
|
|
HY-145942-25g
|
MedChemexpress LLC
|
Octenyl succinic anhydride [CAS 26680-54-6]
|
|
COVID-19-immunoregulation
|
|
HY-P99791-1mg
|
MedChemexpress LLC
|
Orilanolimab [CAS 2066544-85-0]
|
|
COVID-19-immunoregulation
|
|
HY-P99791-10mg
|
MedChemexpress LLC
|
Orilanolimab [CAS 2066544-85-0]
|
|
COVID-19-immunoregulation
|
|
HY-P99791-5mg
|
MedChemexpress LLC
|
Orilanolimab [CAS 2066544-85-0]
|
|
COVID-19-immunoregulation
|
|
HY-A0091-100mg
|
MedChemexpress LLC
|
Pargyline (hydrochloride) [CAS 306-07-0]
|
|
COVID-19-immunoregulation
|
|
HY-A0091-500mg
|
MedChemexpress LLC
|
Pargyline (hydrochloride) [CAS 306-07-0]
|
|
COVID-19-immunoregulation
|
|
HY-A0091-1mL
|
MedChemexpress LLC
|
Pargyline (hydrochloride) [CAS 306-07-0] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-P99814-1mg
|
MedChemexpress LLC
|
Pavurutamab [CAS 2250292-39-6]
|
|
COVID-19-immunoregulation
|
|
HY-P99814-5mg
|
MedChemexpress LLC
|
Pavurutamab [CAS 2250292-39-6]
|
|
COVID-19-immunoregulation
|
|
HY-W141916-100mg
|
MedChemexpress LLC
|
Pentaglycine [CAS 7093-67-6]
|
|
COVID-19-immunoregulation
|
|
HY-W141916-50mg
|
MedChemexpress LLC
|
Pentaglycine [CAS 7093-67-6]
|
|
COVID-19-immunoregulation
|
|
HY-126975-100mg
|
MedChemexpress LLC
|
Propargyl-PEG3-acid [CAS 1347760-82-0]
|
|
COVID-19-immunoregulation
|
|
HY-126975-25mg
|
MedChemexpress LLC
|
Propargyl-PEG3-acid [CAS 1347760-82-0]
|
|
COVID-19-immunoregulation
|
|
HY-126975-50mg
|
MedChemexpress LLC
|
Propargyl-PEG3-acid [CAS 1347760-82-0]
|
|
COVID-19-immunoregulation
|
|
HY-130379-100mg
|
MedChemexpress LLC
|
Propargyl-PEG8-acid [CAS 2055014-94-1]
|
|
COVID-19-immunoregulation
|
|
HY-130379-25mg
|
MedChemexpress LLC
|
Propargyl-PEG8-acid [CAS 2055014-94-1]
|
|
COVID-19-immunoregulation
|
|
HY-130379-50mg
|
MedChemexpress LLC
|
Propargyl-PEG8-acid [CAS 2055014-94-1]
|
|
COVID-19-immunoregulation
|
|
HY-109041-1mg
|
MedChemexpress LLC
|
Razuprotafib [CAS 1008510-37-9]
|
|
COVID-19-immunoregulation
|
|
HY-109041-10mg
|
MedChemexpress LLC
|
Razuprotafib [CAS 1008510-37-9]
|
|
COVID-19-immunoregulation
|
|
HY-109041-25mg
|
MedChemexpress LLC
|
Razuprotafib [CAS 1008510-37-9]
|
|
COVID-19-immunoregulation
|
|
HY-109041-5mg
|
MedChemexpress LLC
|
Razuprotafib [CAS 1008510-37-9]
|
|
COVID-19-immunoregulation
|
|
HY-109041-50mg
|
MedChemexpress LLC
|
Razuprotafib [CAS 1008510-37-9]
|
|
COVID-19-immunoregulation
|
|
HY-109041-1mL
|
MedChemexpress LLC
|
Razuprotafib [CAS 1008510-37-9] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|